Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $5.21 billion. The enterprise value is $5.03 billion.
Important Dates
The last earnings date was Wednesday, April 30, 2025, before market open.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 159.16 million shares outstanding. The number of shares has increased by 6.20% in one year.
| Current Share Class | 159.16M |
| Shares Outstanding | 159.16M |
| Shares Change (YoY) | +6.20% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 0.84% |
| Owned by Institutions (%) | 99.85% |
| Float | 157.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.98 |
| Forward PS | 6.47 |
| PB Ratio | 10.95 |
| P/TBV Ratio | 10.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.66, with a Debt / Equity ratio of 4.14.
| Current Ratio | 9.66 |
| Quick Ratio | 8.74 |
| Debt / Equity | 4.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.18 |
Financial Efficiency
Return on equity (ROE) is -118.62% and return on invested capital (ROIC) is -12.51%.
| Return on Equity (ROE) | -118.62% |
| Return on Assets (ROA) | -10.59% |
| Return on Invested Capital (ROIC) | -12.51% |
| Return on Capital Employed (ROCE) | -18.44% |
| Revenue Per Employee | $670,957 |
| Profits Per Employee | -$428,468 |
| Employee Count | 1,069 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 43.03 |
Taxes
| Income Tax | -6.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.99% in the last 52 weeks. The beta is 0.15, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -19.99% |
| 50-Day Moving Average | 30.92 |
| 200-Day Moving Average | 37.08 |
| Relative Strength Index (RSI) | 60.43 |
| Average Volume (20 Days) | 1,768,046 |
Short Selling Information
The latest short interest is 14.55 million, so 9.14% of the outstanding shares have been sold short.
| Short Interest | 14.55M |
| Short Previous Month | 13.34M |
| Short % of Shares Out | 9.14% |
| Short % of Float | 9.22% |
| Short Ratio (days to cover) | 7.64 |
Income Statement
In the last 12 months, IONS had revenue of $717.25 million and -$458.03 million in losses. Loss per share was -$3.00.
| Revenue | 717.25M |
| Gross Profit | -181.15M |
| Operating Income | -472.43M |
| Pretax Income | -352.50M |
| Net Income | -458.03M |
| EBITDA | -460.85M |
| EBIT | -472.43M |
| Loss Per Share | -$3.00 |
Full Income StatementBalance Sheet
The company has $2.15 billion in cash and $1.97 billion in debt, giving a net cash position of $179.68 million or $1.13 per share.
| Cash & Cash Equivalents | 2.15B |
| Total Debt | 1.97B |
| Net Cash | 179.68M |
| Net Cash Per Share | $1.13 |
| Equity (Book Value) | 475.73M |
| Book Value Per Share | 2.99 |
| Working Capital | 2.17B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$501.78 million and capital expenditures -$53.36 million, giving a free cash flow of -$555.15 million.
| Operating Cash Flow | -501.78M |
| Capital Expenditures | -53.36M |
| Free Cash Flow | -555.15M |
| FCF Per Share | -$3.49 |
Full Cash Flow StatementMargins
Gross margin is -25.26%, with operating and profit margins of -65.87% and -63.86%.
| Gross Margin | -25.26% |
| Operating Margin | -65.87% |
| Pretax Margin | -64.71% |
| Profit Margin | -63.86% |
| EBITDA Margin | -64.25% |
| EBIT Margin | -65.87% |
| FCF Margin | n/a |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.20% |
| Shareholder Yield | -6.20% |
| Earnings Yield | -8.79% |
| FCF Yield | -10.65% |
Dividend DetailsAnalyst Forecast
The average price target for IONS is $57.41, which is 75.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $57.41 |
| Price Target Difference | 75.30% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 25.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IONS has an Altman Z-Score of 0.97 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.97 |
| Piotroski F-Score | 1 |